Evaluation of the effectiveness of the use of iron carboxymaltosate in late pregnancy and in the postpartum period
https://doi.org/10.21886/2712-8156-2023-4-4-83-88
Abstract
Objective: to evaluate the effectiveness of the use of iron carboxymaltosate in late pregnancy and in the postpartum period. Materials and methods: dynamic observation of the effectiveness of iron carboxymaltosate in 46 pregnant women diagnosed with anemia, latent iron deficiency due to the lack of positive dynamics against the background of taking oral forms of iron preparations, complaining of palpitations, shortness of breath with minimal physical exertion, weakness. The assessment was carried out by the level of hemoglobin (Hb), ferritin a month after the treatment with a high-dose iron preparation intravenously drip. The follow–up period is the third trimester of pregnancy, 2 days after delivery, a month after delivery. Results: the treatment with iron of carboxymaltosate led to an increase in the Hb level of 18±3 g/l, the ferritin level of 70±35 mcg/l a month after the infusion, and an improvement in the clinical condition. Conclusion: the use of iron carboxymaltose in the late stages of pregnancy allows to quickly normalize and maintain target values of hemoglobin and ferritin levels for a long time, already during the postpartum period, as well as improve the quality of life of women.
About the Authors
M. K. BartsitsRussian Federation
Maritsa K. Bartsits - clinical pharmacologist, State budgetary institution Rostov region “Perinatal center”.
Rostov-on-Don
A. V. Safronenko
Russian Federation
Andrey V. Safronenko - Dr. Sci. (Med.), Docent, Head of the Department of pharmacology and clinical pharmacology, Federal State Budget Educational Institution of Higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation.
Rostov-on-Don
E. V. Gantsgorn
Russian Federation
Elena V. Gantsgorn - Cand. Sci. (Med.), Docent, Associate professor of the Department of pharmacology and clinical pharmacology, Federal State Budget Educational Institution of Higher Education “Rostov State Medical University” of the Ministry of Health of the Russian Federation.
Rostov-on-Don
M. N. Umansky
Russian Federation
Maxim N. Umansky - Candidate of Medical Sciences, Chief Physician of the State budgetary institution Rostov region “Perinatal Center”.
Rostov-on-Don
References
1. Vogel JP, Souza JP, Mori R, Morisaki N, Lumbiganon P, Laopaiboon M, et al. Maternal complications and perinatal mortality: findings of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121 Suppl 1:76-88. Erratum in: BJOG. 2015;122(3):451. PMID: 24641538. DOI: 10.1111/1471-0528.12633.
2. Wiegersma AM, Dalman C, Lee BK, Karlsson H, Gardner RM. Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders. JAMA Psychiatry. 2019;76(12):1294-1304. DOI: 10.1001/jamapsychiatry.2019.2309
3. Бурлев В.А., Коноводова Е.Н. Железодефицитные состояния у беременных и родильниц. Рациональная фармакотерапия в акушерстве и гинекологии. 2-е издание испр. и доп. Под ред. Серова В.Н., Сухих Г.Т. 2010.
4. Leung TW, Damodaran P, Torres R, Chuncharunee S, Chu MY, Gamilla Z, et al. Expert consensus on improving iron deficiency anemia management in obstetrics and gynecology in Asia. Int J Gynaecol Obstet. 2023;163(2):495-509. DOI: 10.1002/ijgo.14804
5. Sinha A, Adhikary M, Phukan JP, Kedia S, Sinha T. A study on anemia and its risk factors among pregnant women attending antenatal clinic of a rural medical college of West Bengal. J Family Med Prim Care. 2021;10(3):1327-1331. DOI: 10.4103/jfmpc.jfmpc_1588_20
6. Gupte SA, Venkataraman G, Shah AS, Mudholkar AS, Jangam SM. Clinical effects and safety of ferric carboxymaltose in pregnancy: An Indian real-life experience. J Obstet Gynaecol Res. 2021;47(10):3464-3470. DOI: 10.1111/jog.14956
7. Bansal R, Bedi M, Kaur J, Kaur K, Shergill HK, Khaira HK, et al. Prevalence and factors associated with anemia among pregnant women attending antenatal clinic. Adesh Univ J Med Sci Res. 2020;2(1):42-8. DOI: 10.25259/AUJMSR_8_2020
8. Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC Pregnancy Childbirth. 2019;19(1):54. DOI: 10.1186/s12884-019-2200-3
9. Hansen R, Spangmose AL, Sommer VM, Holm C, Jørgensen FS, Krebs L, et al. Maternal first trimester iron status and its association with obstetric and perinatal outcomes. Arch Gynecol Obstet. 2022;306(4):1359-1371. DOI: 10.1007/s00404-022-06401-x
10. Chauhan J, Pratapbhai KV, Mahalakshmi, Pandya M. Efficacy and safety of ferric carboxymaltose in anemia in pregnancy. Int J Clin Obstet Gynaecol 2020;4(6):292-295. DOI: 10.33545/gynae.2020.v4.i6e.769
11. Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, et al. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. Semin Hematol. 2018;55(4):223-234. DOI: 10.1053/j.seminhematol.2018.04.006
12. Rogozińska E, Daru J, Nicolaides M, Amezcua-Prieto C, Robinson S, Wang R, et al. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. Lancet Haematol. 2021;8(7):e503-e512. DOI: 10.1016/S2352-3026(21)00137-X
13. ElAlfy MS, El-Farrash RA, Taha HM, Ismail EA, Mokhtar NA. Auditory brainstem response in full-term neonates born to mothers with iron deficiency anemia: relation to disease severity. J Matern Fetal Neonatal Med. 2020;33(11):1881-1888. DOI: 10.1080/14767058.2018.1533940
14. Клинические рекомендации. Кровесберегающие технологии в акушерской практике. 2014.
15. Belousov Yu.B. Ethical review of biomedical research. Practical recommendations. M.: Publishing House of the Society of Clinical Researchers, 2005.
Review
For citations:
Bartsits M.K., Safronenko A.V., Gantsgorn E.V., Umansky M.N. Evaluation of the effectiveness of the use of iron carboxymaltosate in late pregnancy and in the postpartum period. South Russian Journal of Therapeutic Practice. 2023;4(4):83-88. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-4-83-88